Tesamorelin and metabolic effects in patients with HIV · 2007
Clinical research examined abdominal fat and metabolic outcomes in adults with HIV-associated fat accumulation. Results apply to the studied population and formulation.
Read source
FSD BIO LABS · Product artwork
Studied for growth hormone signalling and changes in visceral abdominal fat.
20 vials available
Full prepaid by UPI includes free delivery. COD requires 5% advance and a 1.5% delivery fee. Payment details
See delivery information and return conditions before ordering. Your final total is shown at checkout.
2 laboratory reports available
Not for human or veterinary administration. Listed strength is a supplied specification; see the matching batch report for measured results.
2 reports are available for this strength. Match the reported sample and available batch identifiers; contact support if the link to your vial is unclear.
View COA libraryTesamorelin is an analogue of growth hormone-releasing hormone (GHRH). Clinical research has examined its effects on visceral fat, including in adults with HIV-associated abdominal fat accumulation.
Each source identifies what was studied and the limits of its findings. Published research is separate from this product’s batch COA.
Clinical research examined abdominal fat and metabolic outcomes in adults with HIV-associated fat accumulation. Results apply to the studied population and formulation.
Read sourceA placebo-controlled trial studied liver fat in people with HIV and non-alcoholic fatty liver disease. The findings concern a defined clinical population and formulation, not general weight loss or this research material.
Read sourceTESAMORELIN is currently listed in 10 mg. Select a strength above to see its price, product image and current stock. Listed quantities are supplied specifications, not measured batch results.
2 laboratory reports are published for this compound. Match the selected strength and available batch identifiers, and open the original document to check the actual test scope.
The references discuss the material and experimental conditions in those studies. They do not verify the identity, purity, quantity or suitability of this catalogue vial. Review the study limitations and the available batch documentation separately.